CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 86  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0515
LYS 10.0243
GLU 20.0294
LEU 30.0257
ARG 40.0243
CYS 50.0039
GLN 60.0075
CYS 70.0237
ILE 80.0188
LYS 90.0145
THR 100.0125
TYR 110.0125
SER 120.0204
LYS 130.0468
PRO 140.0234
PHE 150.0041
HIS 160.0099
PRO 170.0146
LYS 180.0258
PHE 190.0117
ILE 200.0130
LYS 210.0169
GLU 220.0218
LEU 230.0246
ARG 240.0058
VAL 250.0120
ILE 260.0147
GLU 270.0176
SER 280.0155
GLY 290.0428
PRO 300.0247
HIS 310.0207
CYS 320.0069
ALA 330.0417
ASN 340.0140
THR 350.0213
GLU 360.0128
ILE 370.0113
ILE 380.0089
VAL 390.0121
LYS 400.0222
LEU 410.0168
SER 420.0106
ASP 430.0095
GLY 440.0249
ARG 450.0225
GLU 460.0340
LEU 470.0155
CYS 480.0092
LEU 490.0094
ASP 500.0129
PRO 510.0093
LYS 520.0515
GLU 530.0095
ASN 540.0302
TRP 550.0268
VAL 560.0307
GLN 570.0412
ARG 580.0358
VAL 590.0154
VAL 600.0229
GLU 610.0302
LYS 620.0226
PHE 630.0121
LEU 640.0143
LYS 650.0216
ARG 660.0137
ALA 670.0322
GLU 680.0142
ASN 690.0077

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.